Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Gahr

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Fortschritte Der Neurologie-Psychiatrie|May 25, 2022
[Kratom (Mitragyna Speciosa): a Psychoactive Plant with Opportunities and Risks]Maximilian Gahr
Fortschritte Der Neurologie-Psychiatrie|June 7, 2022
[Correction: Kratom (Mitragyna Speciosa): a Psychoactive Plant with Opportunities and Risks]Maximilian Gahr
Deutsches Arzteblatt International|May 15, 2023
Insufficient Healthcare ServicesMaximilian Gahr
Deutsches Arzteblatt International|December 10, 2024
Psychopharmatherapeutic OptionsMaximilian Gahr
MMW Fortschritte Der Medizin|September 15, 2017
[Diagnosis and therapy of insomnia and basic aspects of other sleep disorders]Maximilian Gahr
Der Nervenarzt|June 12, 2025
[Benefits and risks of gabapentinoids in geriatric psychiatry]Maximilian Gahr
Current Neuropharmacology|November 27, 2014
Agomelatine in the treatment of major depressive disorder: an assessment of benefits and risksMaximilian Gahr
Fortschritte Der Neurologie-Psychiatrie|October 15, 2019
[Caffeine, the most frequently consumed psychostimulant: a narrative review article]Maximilian Gahr
Fortschritte Der Neurologie-Psychiatrie|September 23, 2024
[Metabolic adverse drug reactions related to psychotropic drugs]Maximilian Gahr
Der Nervenarzt|July 22, 2025
[Akathisia related to antipsychotics: mirtazapine as a therapeutic option?]Elena Böttcher, Maximilian Gahr
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Fortschritte Der Neurologie-Psychiatrie|May 25, 2022
[Kratom (Mitragyna Speciosa): a Psychoactive Plant with Opportunities and Risks]Maximilian Gahr
Fortschritte Der Neurologie-Psychiatrie|June 7, 2022
[Correction: Kratom (Mitragyna Speciosa): a Psychoactive Plant with Opportunities and Risks]Maximilian Gahr
Deutsches Arzteblatt International|May 15, 2023
Insufficient Healthcare ServicesMaximilian Gahr
Deutsches Arzteblatt International|December 10, 2024
Psychopharmatherapeutic OptionsMaximilian Gahr
MMW Fortschritte Der Medizin|September 15, 2017
[Diagnosis and therapy of insomnia and basic aspects of other sleep disorders]Maximilian Gahr
Der Nervenarzt|June 12, 2025
[Benefits and risks of gabapentinoids in geriatric psychiatry]Maximilian Gahr
Current Neuropharmacology|November 27, 2014
Agomelatine in the treatment of major depressive disorder: an assessment of benefits and risksMaximilian Gahr
Fortschritte Der Neurologie-Psychiatrie|October 15, 2019
[Caffeine, the most frequently consumed psychostimulant: a narrative review article]Maximilian Gahr
Fortschritte Der Neurologie-Psychiatrie|September 23, 2024
[Metabolic adverse drug reactions related to psychotropic drugs]Maximilian Gahr
Der Nervenarzt|July 22, 2025
[Akathisia related to antipsychotics: mirtazapine as a therapeutic option?]Elena Böttcher, Maximilian Gahr
Pageof 11